Peter Heger,Reinhard Rettenberger,Carl-Friedrich Spaich
申请号：
US13621775
公开号：
US20130035305A1
申请日:
2012.09.17
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The invention relates to the use of a combination of active ingredients, selected from resveratrol and piceatannol precursors and functional derivatives thereof, in addition to the use of the stereoisomeric forms of said ingredients, in the form of salts or phenol respectively, for producing an agent for the prevention and/or treatment of diseases, whose occurrence and/or progress is associated with an increased IL-6 serum level and/or whose occurrence and/or progress can be treated by a dose of a selective oestrogen receptor .beta. (ER-β) agonist.
